Imunon, Inc.
General ticker "IMNN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $12.6M (TTM average)
Imunon, Inc. does not follow the US Stock Market performance with the rate: -35.9%.
Estimated limits based on current volatility of 4.3%: low 1.26$, high 1.38$
Factors to consider:
- Total employees count: 20 (-20.0%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Significant losses, Going concern doubt, Capital raising, Failed drug development, Regulatory and compliance
- Current price 18.8% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.58$, 5.23$]
- 2026-12-31 to 2027-12-31 estimated range: [1.01$, 3.37$]
Financial Metrics affecting the IMNN estimates:
- Negative: with PPE of -0.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: 49.86 < Shareholder equity ratio, % of 57.47 <= 58.56
- Positive: Interest expense per share per price, % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: -4.49 < Investing cash flow per share per price, % of -3.75
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term IMNN quotes
Long-term IMNN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $21.03MM | $19.13MM | $14.65MM |
| Operating Income | $-21.03MM | $-19.13MM | $-14.65MM |
| Non-Operating Income | $0.24MM | $0.51MM | $0.16MM |
| Interest Expense | $0.20MM | $0.00MM | $0.00MM |
| R&D Expense | $11.29MM | $11.64MM | $7.78MM |
| Income(Loss) | $-20.80MM | $-18.62MM | $-14.50MM |
| Taxes | $-1.28MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-19.51MM | $-18.62MM | $-14.49MM |
| Stockholders Equity | $13.39MM | $4.24MM | $7.06MM |
| Assets | $21.92MM | $9.72MM | $12.29MM |
| Operating Cash Flow | $-19.02MM | $-18.85MM | $-13.90MM |
| Capital expenditure | $0.45MM | $0.03MM | $0.28MM |
| Investing Cash Flow | $11.01MM | $9.83MM | $-0.28MM |
| Financing Cash Flow | $-3.64MM | $9.06MM | $17.09MM |
| Earnings Per Share** | $-28.14 | $-21.10 | $-6.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.